Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Silver

Showing results (201-210 of 210) with videos related to

Pageof 21
Sort By:
You have reached the last page of results.This site can display upto 210 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 17, 2018
Overexpression of BLM promotes DNA damage and increased sensitivity to platinum salts in triple-negative breast and serous ovarian cancersN J Birkbak, Y Li, S Pathania, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 5, 2019
Association of Tumor-Infiltrating Lymphocytes with Homologous Recombination Deficiency and <i>BRCA1/2</i> Status in Patients with Early Triple-Negative Breast Cancer: A Pooled AnalysisMelinda L Telli, Charles Chu, Sunil S Badve, et al.
Cancer Cell|April 20, 2004
Endogenous oncogenic K-ras(G12D) stimulates proliferation and widespread neoplastic and developmental defectsDavid A Tuveson, Alice T Shaw, Nicholas A Willis, et al.
Breast Cancer Research : BCR|November 18, 2010
Prevalence and predictors of loss of wild type BRCA1 in estrogen receptor positive and negative BRCA1-associated breast cancersNadine Tung, Alexander Miron, Stuart J Schnitt, et al.
Trends in Biochemical Sciences|August 11, 1998
Unified nomenclature for subunits of the Saccharomyces cerevisiae proteasome regulatory particleD Finley, K Tanaka, C Mann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 27, 2010
Efficacy of neoadjuvant Cisplatin in triple-negative breast cancerDaniel P Silver, Andrea L Richardson, Aron C Eklund, et al.
Breast Cancer Research and Treatment|May 6, 2020
Prognostic value of HER2 status on circulating tumor cells in advanced-stage breast cancer patients with HER2-negative tumorsChun Wang, Zhaomei Mu, Zhong Ye, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 10, 2016
Homologous Recombination Deficiency (HRD) Score Predicts Response to Platinum-Containing Neoadjuvant Chemotherapy in Patients with Triple-Negative Breast CancerMelinda L Telli, Kirsten M Timms, Julia Reid, et al.
European Journal of Cancer (Oxford, England : 1990)|December 12, 2018
Association of clinical outcomes in metastatic breast cancer patients with circulating tumour cell and circulating cell-free DNAZhong Ye, Chun Wang, Shaogui Wan, et al.
Nature|December 25, 2009
Complex landscapes of somatic rearrangement in human breast cancer genomesPhilip J Stephens, David J McBride, Meng-Lay Lin, et al.
Pageof 21

Showing results (201-210 of 210) with videos related to

Sort By:
Pageof 21
You have reached the last page of results.This site can display upto 210 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 17, 2018
Overexpression of BLM promotes DNA damage and increased sensitivity to platinum salts in triple-negative breast and serous ovarian cancersN J Birkbak, Y Li, S Pathania, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 5, 2019
Association of Tumor-Infiltrating Lymphocytes with Homologous Recombination Deficiency and <i>BRCA1/2</i> Status in Patients with Early Triple-Negative Breast Cancer: A Pooled AnalysisMelinda L Telli, Charles Chu, Sunil S Badve, et al.
Cancer Cell|April 20, 2004
Endogenous oncogenic K-ras(G12D) stimulates proliferation and widespread neoplastic and developmental defectsDavid A Tuveson, Alice T Shaw, Nicholas A Willis, et al.
Breast Cancer Research : BCR|November 18, 2010
Prevalence and predictors of loss of wild type BRCA1 in estrogen receptor positive and negative BRCA1-associated breast cancersNadine Tung, Alexander Miron, Stuart J Schnitt, et al.
Trends in Biochemical Sciences|August 11, 1998
Unified nomenclature for subunits of the Saccharomyces cerevisiae proteasome regulatory particleD Finley, K Tanaka, C Mann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 27, 2010
Efficacy of neoadjuvant Cisplatin in triple-negative breast cancerDaniel P Silver, Andrea L Richardson, Aron C Eklund, et al.
Breast Cancer Research and Treatment|May 6, 2020
Prognostic value of HER2 status on circulating tumor cells in advanced-stage breast cancer patients with HER2-negative tumorsChun Wang, Zhaomei Mu, Zhong Ye, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 10, 2016
Homologous Recombination Deficiency (HRD) Score Predicts Response to Platinum-Containing Neoadjuvant Chemotherapy in Patients with Triple-Negative Breast CancerMelinda L Telli, Kirsten M Timms, Julia Reid, et al.
European Journal of Cancer (Oxford, England : 1990)|December 12, 2018
Association of clinical outcomes in metastatic breast cancer patients with circulating tumour cell and circulating cell-free DNAZhong Ye, Chun Wang, Shaogui Wan, et al.
Nature|December 25, 2009
Complex landscapes of somatic rearrangement in human breast cancer genomesPhilip J Stephens, David J McBride, Meng-Lay Lin, et al.
Pageof 21